NuPulse iVAS Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study
A Study of NuPulseCV intravascular ventricular assist balloon system (iVAS) in promoting blood circulation in Heart Failure
Sponsor: NuPulse, Inc.
Enrolling: Male and Female Patients
Study Length: 1 Years
Clinic Visits: 16
IRB Number: AAAS1409
U.S. Govt. ID: NCT02645539
Contact: Anel Paulino, Clinical Research Coordinator: (212) 305-3009 /
Additional Study Information: The purpose of this study is to evaluate the NuPulseCV intravascular ventricular assist system (iVAS), a device similar to an Intra-aortic Balloon Pump (IABP) that helps circulate blood from the heart throughout the rest of the body. This study aims to: (1) See if the iVAS improves your blood circulation (2) Better understand how the iVAS device could impact your health (3) Observe human interaction with the iVAS device (4) Assess the portability of the iVAS device. The NuPulseCV iVAS is an experimental device, which means that it has not yet been approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced heart failure in patients.
This study is closed
Koji Takeda, MD, PhD
Do You Qualify?
Are you 18 years of age or older? Yes No
Do you have advanced heart failure? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Anel Paulino, Clinical Research Coordinator
(212) 305-3009